NeuroPace (NPCE) Operating Leases (2022 - 2026)

NeuroPace's Operating Leases history runs 5 years deep, the most recent figure standing at $11.4 million for Q1 2026.

• In Q1 2026, Operating Leases fell 14.39% year-over-year to $11.4 million; the TTM figure through Mar 2026 stood at $11.4 million (down 14.39% YoY), while the FY2025 annual figure was $9.8 million, down 17.71% from the prior year.
• Operating Leases was $11.4 million for Q1 2026 at NeuroPace, up from $9.8 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $16.4 million in Q3 2022 to a low of $3.2 million in Q2 2022.
• Historically, Operating Leases has averaged $12.6 million across 5 years, with a median of $12.9 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Operating Leases surged 354.36% in 2023, then decreased 21.34% in 2024.
• A 5-year view of Operating Leases shows it stood at $15.4 million in 2022, then fell by 10.53% to $13.8 million in 2023, then declined by 13.47% to $12.0 million in 2024, then retreated by 17.71% to $9.8 million in 2025, then increased by 16.32% to $11.4 million in 2026.
• The last three Operating Leases figures came in at $11.4 million (Q1 2026), $9.8 million (Q4 2025), and $12.4 million (Q3 2025), per Business Quant data.